3PRISCILLE B, IDA R, PETER A, et al. ESAT-6 proteins: protective antigens and virulence faetors?[J]. Trends in Microbiology, 2004, 12(11) : 500 - 508.
4MORTEN H, THOMAS O, HARALD G W, et al. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium boris and for its absence in Mycobacterium bovis BCG[J]. Infection and Immunity, 1996, 64(1): 16-22.
5KRISHAN K, MEGHA T, SWETHA G, et al. Phenylalaninerich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growth[J]. Anti Mycobacterial Peptidcs, 2009, 4 (11): 1-12.
6SERGE M, CYNTMIA C, DAVID R S, et al. The Mycobacterium tuberculosis complex tramcriptome of attenuation[J]. Tuberculosis, 2004, 84: 197-204.
7BUKA S, XISHENG WANG, PETER F B. Mycobacterium tuberculosis KSX-1 system-secreted protein ESAT-6 but not CFP10 inhibits human T-cell immune responses[J]. Tubercu- losis, 2009, SI: S74- S76.
10KRISTI M G, MARK J H, SANJEEV K M, et al. Individual RDl-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis[ J ]. Molecular microbiology, 2004, 51(2): 359-370.
二级参考文献86
1Wang C Y, James C, Cusack J R, et ai. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibitor of NF-кB. Nature Med, 1999, 5:412-417.
2Rayet B, Gelinas C. Aberrant Rel/NF-кB genes and activity ill human cancer.Oncongene, 1999, 18:6938-6947.
3Iurover M, Petrenko O, Roll R. A chicken c-Relestrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformationand transcriptional activation. Oncogene, 1998, 16:3133-3142.
4Kralora J, Schatzle J D, Bargmann W. Transformation of avian fibroblasts overexpression the c-Rel lacking 40 C-terminal amino acids. J Virol, 1994, 68:2073-2083.
5Barth T E E, Dohner H, Werner C A, et al. Characteristic pattern of chromosomal gains and losses in primary large B cell lymphomas of the gastrointestinal tract. Blood, 1998, 91:4321-4330.
6Muhopadhyay T, Roth J A, Maxwell S A, et al. Altered expression of the p50 subunit of the NF-a Btrafiscription factor complex in non-small cell lung carcinoma. Oncogene, 1995, 11:999-1003.
7Higgins K A, Perez J R, Coleman T A, et al. Antisense inhibition of the p65 subunit of NF-кB blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA, 1993, 90:9901-9905.
8Firrier R, Noigarede R, Doucet S, et al. Physical interaction of the bHLH LYL1 protein and NF-кB1 p105.Oncogene, 1999, 18:995-1003.
9Bours V, Dejardin E, Goujon-Letawe F, et al. The NF-к B transcription factor and cancer: high expression of NF-к B and I к B-related proteins in tumor cell lines. Biochem Pharmacol, 1994, 47:145-149.
10Bours V, Franzoso G, Azarenko V. The oncoprotein Bcl-3 directly transactivates through кB motifs via association with DNA-binging p50B homodimers.Cell. 1993, 72:729-739.
